Deng Peizong, Teng Fangfang, Zhou Feilong, Song Zhimei, Meng Ning, Liu Na, Feng Runliang
School of Biological Science and Technology, University of Jinan, No. 336 West Road of Nanxinzhuang, Jinan 250022, Shandong Province, PR China.
School of Medicine and Life Sciences, University of Jinan-Shandong Academy of Medical Sciences, No. l6866 East Road of Jingshi, Jinan 250200, Shandong Province, PR China; Shandong Academy of Medical Sciences, No. 18877 Jingshi Road, Jinan 250062, Shandong Province, PR China.
Mater Sci Eng C Mater Biol Appl. 2017 Sep 1;78:296-304. doi: 10.1016/j.msec.2017.04.089. Epub 2017 Apr 17.
Ketoconazole is a hydrophobic broad-spectrum antifungal agent for skin infection therapy. In order to develop topical formulation of ketoconazole for improving its selective skin deposition and water-solubility, ketoconazole-loaded Y-shaped monomethoxy poly(ethylene glycol)-block-poly(ɛ-caprolactone) micelles were prepared through thin-film hydration method with high entrapment efficiency (96.1±0.76%) and small particle (about 58.66nm). The drug-loaded micelles showed comparative in vitro antimicrobial activity with KET cream. In ex in vivo skin deposition and permeation study, ketoconazole-loaded micelles provided skin accumulation higher than marketed ketoconazole cream without obvious permeation in the whole period. Fluorescence microscopy study and histopathological study demonstrated the copolymeric micelles' penetrating into skin in depth due to its capability of weakening the barrier function of stratum corneum. In vivo skin deposition parameters further confirmed high skin deposition of drug-loaded micelles (AUC=396.16μg·h/cm) over marketed ketoconazole cream (AUC=250.03μg·h/cm). Meanwhile, in vivo pharmacokinetic parameters proved that ketoconazole-loaded micelles reduced ketoconazole's distribution in blood in comparison with the cream (AUC=93,028.00μg·h/L vs AUC=151,714.00μg·h/L), meaning lower possibility of its systemic unwanted effects in the skin fungal infection treatment. The results suggested that the copolymeric micelles can be adopted for specific delivering ketoconazole into skin for fungal infection cure.
酮康唑是一种用于皮肤感染治疗的疏水性广谱抗真菌剂。为了开发酮康唑的局部制剂以提高其在皮肤中的选择性沉积和水溶性,通过薄膜水化法制备了负载酮康唑的Y形单甲氧基聚(乙二醇)-嵌段-聚(ε-己内酯)胶束,其包封率高(96.1±0.76%)且粒径小(约58.66nm)。载药胶束在体外显示出与酮康唑乳膏相当的抗菌活性。在体内皮肤沉积和渗透研究中,负载酮康唑的胶束在整个时间段内的皮肤蓄积高于市售酮康唑乳膏,且无明显渗透。荧光显微镜研究和组织病理学研究表明,共聚物胶束由于其削弱角质层屏障功能的能力而能够深入皮肤。体内皮肤沉积参数进一步证实了载药胶束(AUC=396.16μg·h/cm)比市售酮康唑乳膏(AUC=250.03μg·h/cm)具有更高的皮肤沉积。同时,体内药代动力学参数证明,与乳膏相比,负载酮康唑的胶束减少了酮康唑在血液中的分布(AUC=93,028.00μg·h/L对AUC=151,714.00μg·h/L),这意味着在皮肤真菌感染治疗中其产生全身不良反应的可能性较低。结果表明,共聚物胶束可用于将酮康唑特异性递送至皮肤以治疗真菌感染。